Status:
COMPLETED
Effect of Degree of Polymerization and Linkage of α-glucans on Post-prandial Glucose Response
Lead Sponsor:
Société des Produits Nestlé (SPN)
Conditions:
Postprandial Glucose Response
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The primary research project objective is to investigate whether a maltodextrin with high degree of polymerization (Roquette Glucidex 2) and a dextran with comparable degree of polymerization (Pharmac...
Detailed Description
The aim of the present research project is to generate comparative data on post-prandial glucose response (PPGR) of α-glucans varying systematically degree of polymerization and linkage type. These da...
Eligibility Criteria
Inclusion
- Male and female participant
- Healthy status (based on anamnesis)
- Age between 18 and 45 years
- BMI between 18.5 and 29.9 kg/m2
- Able to understand and sign an informed consent form
- Able to respect the study procedures and timelines
- Swiss resident living in canton Fribourg (French part), Neuchâtel, Vaud and Valais which is in the competence of Ethical Committee of Vaud
- Having wireless internet access at home
Exclusion
- Any known metabolic disease including diabetes or drug chronic intake (aspirin, vitamin C and mineral supplements, steroids, protease inhibitors, antidepressants, anxiolytic, or antipsychotics…) possibly impacting (to the opinion of the medical responsible): The digestion or absorption of nutrients, the postprandial glucose response
- Major medical/surgical event requiring hospitalization in the last 3 months
- Pregnancy or lactation
- Known food allergy and intolerance
- Medically known cutaneous hypersensitivity to adhesives, silicon watch-strap and plasters
- Alcohol intake higher than 2 servings per day. A serving is 0.4 dl of strong alcohols, 1 dl of red or white wine, or 3 dl of beer.
- Smokers
- Participant having a hierarchical link with the research team members
Key Trial Info
Start Date :
November 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 18 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05266690
Start Date
November 29 2019
End Date
February 18 2020
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nestlé Research - Clinical Research Unit - Clinical Innovation Lab
Lausanne, Canton of Vaud, Switzerland, 1000